Pfizer Needs AstraZeneca More Than Ever as Generics Increase - Presented by: The Aol. On Network

Pfizer shares are slipping after the drug maker posted first-quarter profits 15 percent lower than a year earlier and revenue down 9 percent. Net income of 57 cents a share beat expectations by 2 cents, but $11.3 billion in sales fell short of analysts' estimates of $12.1 billion. The weaker-than-expected report comes days after its latest offer to purchase British drug maker AstraZeneca for $106 billion was rejected.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.965 0.09 ▼ 0.50%
PBR $ 13.49 0.70 ▼ 4.93%
F $ 14.58 0.21 ▼ 1.42%
FB $ 76.76 2.28 ▼ 2.88%
QQQ $ 97.615 1.18 ▼ 1.19%
SIRI $ 3.45 0.04 ▼ 1.15%
CSCO $ 25.14 0.03 ▼ 0.12%
AAPL $ 99.7399 1.01 ▼ 1.00%

As of 10/1/2014, 12:42 PM
More Most Active